Trial Profile

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 04 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Feb 2026 According to AdvanCell media release, the trial is open at clinical sites in Australia, with planned expansion to additional sites in the United States.
24 Feb 2026 According to AdvanCell media release, The study design will be showcased in a Trials in Progress poster at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2026)
20 Feb 2026 Five primary efficacy end-points have been added. Study design is changed from sequential to randomised, parallel.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com